The Patent Finder

Medigene AG

Also on record
Records under this name other than the patents Medigene AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Medigene AG

PatentTitleStatus Expires Confidence
US 10,413,511Liposomal formulations of lipophilic compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,858,662Medicament for the treatment of viral skin and tumour diseases
Formerly held
Term ended
Term ended Oct 2, 2026 · From the USPTO record
Term endedTerm ended Oct 2, 2026From the USPTO record
US 9,827,196Method of administering a cationic liposomal preparation
Lapsed on the fee record
Ended Nov 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 28, 2025From the USPTO record
US 7,932,253Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
Term ended
Term ended Aug 23, 2025 · From the USPTO record
Term endedTerm ended Aug 23, 2025From the USPTO record
US 9,707,204Treatment of breast cancer
Formerly held
Lapsed on the fee record
Ended Jul 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2025From the USPTO record
US 9,770,406Medicament for the treatment of viral skin and tumour diseases
Formerly held
Term ended
Term ended Jul 12, 2025 · From the USPTO record
Term endedTerm ended Jul 12, 2025From the USPTO record
US 7,566,713Immuno inhibitory heterocyclic compounds
Term ended
Term ended Apr 26, 2025 · From the USPTO record
Term endedTerm ended Apr 26, 2025From the USPTO record
US 8,455,022Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
Formerly held
Term ended
Term ended Oct 8, 2024 · From the USPTO record
Term endedTerm ended Oct 8, 2024From the USPTO record
US 8,309,552Immunomodulating heterocyclic compounds
Term ended
Term ended Oct 2, 2024 · From the USPTO record
Term endedTerm ended Oct 2, 2024From the USPTO record
US 8,168,216Treatment of triple receptor negative breast cancer
Formerly held
Lapsed on the fee record
Ended May 1, 2024 · From the USPTO record
Lapsed on the fee recordEnded May 1, 2024From the USPTO record
10 of 55 patents shown.
Pro members see all 55.
Pro members: see all 55 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited